Covid-19 Antigen Rapid Test Kit produced by Beijing Beier enter into EU Common list category A

Under the background of the normalization of the Covid-19 epidemic, the overseas demand for Covid-19 antigen products has also changed from the previous emergency demand to the normal demand, and the market is still broad.
As we all know, the EU's access requirements for Covid-19 antigen products are very high, and the EU Health Safety Committee HSC Common List (EU General White List) is currently the most authoritative antigen detection reagent list in the EU. Being able to enter the Common List, which is officially approved by the European Union, can prove that the quality of the product is recognized by the European Union.

At present, the products on the HSC Common List (EU General White List) are divided into two categories: through prospective clinical trial studies, they will enter the Category A list; Through retrospective clinical trial studies, it will enter the Category B list.
Reagent test results from both Class A and B manufacturers can be used to issue electronic certificates of COVID-19 test results, but EU member states are more likely to recognize the test results of Class A manufacturers' reagents than those of Class B manufacturers.
Covid-19 Antigen Rapid Test Kit successful entry into the HSC common list Category A list, it shows that the kit has excellent performance.